Large-scale testing (Phase 3)Ended earlyNCT02600429
What this trial is testing
Assessment of the Safety and Efficacy Study of RGN-259 Ophthalmic Solutions for Neurotrophic Keratopathy : SEER-1
Who this might be right for
Neurotrophic Keratopathy
ReGenTree, LLC 18